The Doctors Will See You Now...
-
The Spartan™ reduces drug diversions, enhances patient education material; controls samples; complies with rules, laws, and regulations at a local, state, and national level; documents activities within each practice; mitigates risk; protects the patient; enhances efficiencies; creates a chain of custody of the therapies used; provides one-of-a kind, never before seen data relating to sample, e-Script, and voucher utilization at the point of treatment (with real time integrity and accuracy.)
-
In addition, the Spartan™ improves the following operations for the pharma company: more health care providers (HCPs) are contacted (Reach); more calls are realized at a substantially higher rate (Frequency); increased share of voice messaging is pulsed according to the desires of the pharma company; a call continuum can be programmed; there will be precise integrity and feedback in a real time format at the point of treatment without any third party manipulations; customizable per HCP specialty; Direct to Consumer access through ads and patient education material; never before realized point of treatment access (Direct-to-Doc pharma portal) relating to messaging (E-Brandaids), as well as, RXs, E-Scripting, Vouchers/E-Vouchers, sampling, etc.
“…It’s getting more and more challenging to get face time with a physician…More than 38% of doctors require appointment…”
(Dave Esclante, president and CEO of SK&A)
“ …68% of practices either requiring an appointment or banning reps altogether.”
(Source: Dave Escalante, President and CEO of SK&A, Pharmacutical Rep Magazine)
“In the past, we were trying to coordinate 10 to 12 different selling teams in primary care. Top-tier physicians could have as many as 175 reps across the industry calling on them. That’s not customer focused, I’d say.”
PHARMACEUTICAL REPRESENTATIVE (February 2008) article titled TOMORROW’S REP, TOMORROWS
MARKET by Joanna Breitstein, David Snow (Vice President, Commercial Operations, AstraZeneca)
"…$20,000,000 annually on free drug samples…” of which approximately 30-35% ($6 billion–$7 billion) never reach the intended targets.”
(Journal of the American Medical Association, 1995)
"…$673,920,000 on a national sales force to make 1,920,000 calls per year.”
(Cooperative Management and Consulting Data, 2009)
